These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 4090436)

  • 1. [Effect of hydralazine on pressure in the pulmonary artery and on blood redistribution in the vessels].
    Koshlia VI
    Vrach Delo; 1985 Oct; (10):53-5. PubMed ID: 4090436
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of hydralazine on the development of tolerance to continuous nitroglycerin.
    Parker JD; Parker AB; Farrell B; Parker JO
    J Pharmacol Exp Ther; 1997 Feb; 280(2):866-75. PubMed ID: 9023301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effect of hydralazine administration on pulmonary artery hemodynamics in dogs with chronic heartworm disease.
    Atkins CE; Keene BW; McGuirk SM; Sato T
    Am J Vet Res; 1994 Feb; 55(2):262-9. PubMed ID: 8172418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydralazine pharmacodynamics in the dog.
    Kittleson MD; Hamlin RL
    Am J Vet Res; 1983 Aug; 44(8):1501-5. PubMed ID: 6625299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phentolamine, hydralazine and alpha blockaders].
    Kigawada R; Tsuyusaki T
    Nihon Rinsho; 1978 Nov; 36(11):3607-12. PubMed ID: 32411
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].
    Dumitriu M; Costică II; Cinteză M; Dăescu L; Bălan C
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(4):349-63. PubMed ID: 6150539
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction.
    Rubin LJ; Lazar JD
    J Clin Invest; 1981 Jan; 67(1):193-200. PubMed ID: 7451649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with hydralazine for treatment of otherwise intractable cough in dogs with apparent left-side heart failure.
    Hamlin RL; Kittleson MD
    J Am Vet Med Assoc; 1982 Jun; 180(11):1327-9. PubMed ID: 7096175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vasodilator drugs in the therapy of chronic congestive heart failure. Clinico-case contribution].
    Artese D; Albani A; Di Tomasso E
    Minerva Med; 1983 Mar; 74(13):715-22. PubMed ID: 6220231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute and chronic congestive heart failure by vasodilator-afterload reduction.
    Mason DT; Awan NA; Joye JA; Lee G; DeMaria AN; Amsterdam EA
    Arch Intern Med; 1980 Dec; 140(12):1577-81. PubMed ID: 6257193
    [No Abstract]   [Full Text] [Related]  

  • 11. The direct effects of vasoactive agents on pulmonary veins. Studies of responses to acetylcholine, serotonin, histamine and isoproterenol in intact dogs.
    Hyman AL
    J Pharmacol Exp Ther; 1969 Jul; 168(1):96-105. PubMed ID: 5792687
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epinephrine induced variations of cardiac output and pulmonary blood volume in the dog with stabilized arterial pressure].
    Paulet G; Le Bars R
    C R Seances Soc Biol Fil; 1967; 161(11):2262-6. PubMed ID: 4232255
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of Metoprolol CR/XL on pulmonary artery pressure in chronic heart failure patients assessed by an implanted ultrasonic device with special emphasis on diurnal variation and exercise capacity.
    Parikh KH; Hetal A; Milan C; Urmil G; Hemang A; Anish C; Ajay M; Ake H; Ramesh K; Parloop A; Rozenman Y
    Indian Heart J; 2009; 61(1):34-9. PubMed ID: 19729686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential use of thiamine in patients with cardiac insufficiency.
    Freye E; Hartung E
    Acta Vitaminol Enzymol; 1982; 4(4):285-90. PubMed ID: 7158589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative evaluation of the effect of digoxin, strophanthin, isolanid and corglycon on the indices of central hemodynamics, vascular tonus, circulating blood volume and myocardial contractility in acute heart failure].
    Tsyganiĭ AA; Kovalev NL; Kozlovskiĭ VI; Malinovskiĭ OP; Pen'kov GI
    Anesteziol Reanimatol; 1981; (3):44-8. PubMed ID: 7294441
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydralazine in heart failure.
    Chatterjee K
    Herz; 1983 Aug; 8(4):187-98. PubMed ID: 6413340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic afterload reduction in the treatment of congestive heart failure.
    Feldman R
    J Iowa Med Soc; 1983 Nov; 73(11):466, 468, 470. PubMed ID: 6361177
    [No Abstract]   [Full Text] [Related]  

  • 19. Dose requirements of hydralazine in patients with severe chronic congestive heart failure.
    Packer M; Meller J; Medina N; Gorlin R; Herman MV
    Am J Cardiol; 1980 Mar; 45(3):655-60. PubMed ID: 7355762
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy and tolerability of hydralazine, in conventional and slow-release preparations, during long-term treatment of primary hypertension.
    Lins LE; Berglund J; Eliasson K; Wernersson B
    Clin Ther; 1983; 5(3):251-9. PubMed ID: 6850719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.